Publications by authors named "Sinai Valdez"

Old age and Cx43 deletion in osteocytes are associated with increased osteocyte apoptosis and osteoclastogenesis. We previously demonstrated that apoptotic osteocytes release elevated concentrations of the proinflammatory cytokine, high mobility group box 1 protein (HMGB1) and apoptotic osteocyte conditioned media (CM) promotes osteoclast differentiation. Further, prevention of osteocyte apoptosis blocks osteoclast differentiation and attenuates the extracellular release of HMGB1 and RANKL.

View Article and Find Full Text PDF
Article Synopsis
  • Loss of bone and muscle mass is a significant issue for elderly individuals, linked to chronic low-grade inflammation and the receptor for advanced glycation end products (RAGE).
  • Treatment with Azeliragon, a RAGE inhibitor, showed no effectiveness in preserving bone mass or structure but did help prevent muscle loss associated with aging.
  • The study highlights that aging affects glucose metabolism differently in bone and muscle, which may explain the varied outcomes of RAGE inhibition on these tissues.
View Article and Find Full Text PDF

Young, skeletally mature mice lacking Cx43 in osteocytes exhibit increased osteocyte apoptosis and decreased bone strength, resembling the phenotype of old mice. Further, the expression of Cx43 in bone decreases with age, suggesting a contribution of reduced Cx43 levels to the age-related changes in the skeleton. We report herein that Cx43 overexpression in osteocytes achieved by using the DMP1-8kb promoter (Cx43 mice) attenuates the skeletal cortical, but not trabecular bone phenotype of aged, 14-month-old mice.

View Article and Find Full Text PDF